Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell

Por Linn, Yeh C, Lau, Siew Kee J, Liu, Bee H, Ng, Lee H, Yong, Hao X, Hui, Kam M
Publicado em 2009

Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Por Hwang, William Y. K., Dearden, Claire, Loh, Yvonne S. M., Linn, Yeh C., Tien, Sim L., Teoh, Gerrard K. H., How, Gee F., Heng, Kee K., Goh, Yeow T., Lee, Lai H.
Publicado em 2009